William Desmarais's most recent trade in Tscan Therapeutics Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 25, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | William Desmarais | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | William Desmarais | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | William Desmarais | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 9.08 per share. | 27 Aug 2021 | 2,500 | 2,500 | - | 9.1 | 22,708 | Voting Common Stock |